Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer
Kei Kudo(National Institutes of Health), Nobuhiro Tanuma(Miyagi Prefectural Hospital Organization)
Cited by 16
Related Papers
Nuclear Inhibitor of Protein Phosphatase-1 (NIPP1) Directs Protein Phosphatase-1 (PP1) to Dephosphorylate the U2 Small Nuclear Ribonucleoprotein Particle (snRNP) Component, Spliceosome-associated Protein 155 (Sap155)
|Journal of Biological Chemistry|2008|55
Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer
|Cancer Gene Therapy|2024|10
Targeting metabolic vulnerability by combining NAMPT inhibitors and disulfiram for treatment of recurrent ovarian cancer
|Cell Death and Disease|2025|3